Tag: Advisory panel
Expert Panel Backs FDA Approval of New Alzheimer’s Drug
An expert panel recently gave its support for the FDA approval of a new drug for Alzheimer's disease called donanemab, manufactured by Eli Lilly. The panel, made up of independent advisors to the FDA,...
Expert Panel Endorses FDA Approval of New Alzheimer’s Drug New Alzheimer’s Drug Receives Expert Panel...
An expert panel has given their endorsement to the FDA approval of a new drug for Alzheimer's disease. The drug, called donanemab and manufactured by Eli Lilly, was found to have modest benefits that...